KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-Term Debt issuances (2021 - 2025)

Elanco Animal Health (ELAN) has disclosed Short-Term Debt issuances for 5 consecutive years, with $125.0 million as the latest value for Q1 2025.

  • Quarterly Short-Term Debt issuances rose 150.0% to $125.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $125.0 million through Dec 2025, down 26.47% year-over-year, with the annual reading at $125.0 million for FY2025, 26.47% down from the prior year.
  • Short-Term Debt issuances hit $125.0 million in Q1 2025 for Elanco Animal Health, up from $120.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $500.0 million in Q2 2022 to a low of -$563.0 million in Q4 2022.
  • Historically, Short-Term Debt issuances has averaged $14.5 million across 5 years, with a median of $100.0 million in 2023.
  • Biggest five-year swings in Short-Term Debt issuances: plummeted 58.0% in 2022 and later surged 150.0% in 2025.
  • Year by year, Short-Term Debt issuances stood at -$500.0 million in 2021, then fell by 12.6% to -$563.0 million in 2022, then skyrocketed by 117.76% to $100.0 million in 2023, then rose by 20.0% to $120.0 million in 2024, then rose by 4.17% to $125.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for ELAN at $125.0 million in Q1 2025, $120.0 million in Q2 2024, and $50.0 million in Q1 2024.